To evaluate that, we treated glioma cells with a panel of MMP14 inhibitors CP101537, CP471474, and Marimastat, (Sigma-Aldrich Corp) that have previously been tested in treatment of glioma 22,23. This evidence concerns the gene MMP14 and central nervous system cancer.